share_log

Cantor Fitzgerald Initiates Coverage On Connect Biopharma Hldgs with Overweight Rating, Announces Price Target of $5

Cantor Fitzgerald Initiates Coverage On Connect Biopharma Hldgs with Overweight Rating, Announces Price Target of $5

坎托·菲茨杰拉德以增持评级启动对Connect Biopharma Hldgs的报道,宣布目标股价为5美元
Benzinga Real-time News ·  2022/06/02 06:26

Cantor Fitzgerald analyst Louise Chen initiates coverage on Connect Biopharma Hldgs (NASDAQ:CNTB) with a Overweight rating and announces Price Target of $5.

坎托·菲茨杰拉德分析师路易丝·陈以增持评级开始对Connect Biopharma Hldgs(纳斯达克股票代码:CNTB)进行报道,并宣布目标股价为5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发